{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:58:26Z","timestamp":1767963506377,"version":"3.49.0"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,15]]},"DOI":"10.1093\/hmg\/ddx323","type":"journal-article","created":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T15:09:13Z","timestamp":1502809753000},"page":"4375-4387","source":"Crossref","is-referenced-by-count":25,"title":["High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3814-6289","authenticated-orcid":false,"given":"Pedro P","family":"Cunha","sequence":"first","affiliation":[]},{"given":"Pedro M","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Catarina M","family":"Morais","sequence":"additional","affiliation":[]},{"given":"In\u00eas R","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Ana M","family":"Cardoso","sequence":"additional","affiliation":[]},{"given":"Ana L","family":"Cardoso","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Mano","sequence":"additional","affiliation":[]},{"given":"Am\u00e1lia S","family":"Jurado","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1844-5027","authenticated-orcid":false,"given":"Maria C","family":"Pedroso de Lima","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2017,8,16]]},"reference":[{"key":"key\n\t\t\t\t20171103044530_ddx323-B1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","year":"2005","journal-title":"N. Engl. J. Med"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ana.22425","article-title":"Current concepts and management of glioblastoma","volume":"70","year":"2011","journal-title":"Ann. Neurol"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"The Cancer Genome Atlas Research Network","year":"2008","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","year":"2010","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ccr.2011.11.005","article-title":"Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma","volume":"20","year":"2011","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The Somatic Genomic Landscape of Glioblastoma","volume":"155","year":"2013","journal-title":"Cell"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B7","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/ng.2734","article-title":"The integrated landscape of driver genomic alterations in glioblastoma","volume":"45","year":"2013","journal-title":"Nat. Genet"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccell.2016.03.012","article-title":"Single-cell phosphoproteomics resolves adaptive signaling dynamics and informs targeted combination therapy in glioblastoma","volume":"29","year":"2016","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tips.2015.04.005","article-title":"FDA-approved small-molecule kinase inhibitors","volume":"36","year":"2015","journal-title":"Trends Pharmacol. Sci"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B10","author":"Sunitinib malate in treating younger patients with recurrent, refractory, or progressive malignant glioma or ependymoma","year":"2011"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B11","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/cam4.713","article-title":"Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children\u2019s Oncology Group Study ACNS1021","volume":"5","year":"2016","journal-title":"Cancer Med"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B12"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11060-016-2092-2","article-title":"Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma","volume":"128","year":"2016","journal-title":"J. Neurooncol"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc3918","article-title":"Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma","volume":"15","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.tibs.2014.08.010","article-title":"Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies","volume":"39","year":"2014","journal-title":"Trends Biochem. Sci"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2174\/1871527314666150116123610","article-title":"MicroRNAs in glioblastoma: role in pathogenesis and opportunities for targeted therapies","volume":"14","year":"2015","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B17","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/onc.2011.380","article-title":"Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases","volume":"31","year":"2012","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B18","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1038\/onc.2011.551","article-title":"MiR-135a functions as a selective killer of malignant glioma","volume":"31","year":"2012","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1073\/pnas.1314341111","article-title":"miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma","volume":"111","year":"2014","journal-title":"Proc. Natl. Acad. Sci"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B20","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/neuonc\/nou084","article-title":"MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras","volume":"16","year":"2014","journal-title":"Neuro Oncol"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B21","doi-asserted-by":"crossref","first-page":"e675.","DOI":"10.1038\/cddis.2013.197","article-title":"CPEB1, a histone-modified hypomethylated gene, is regulated by miR-101 and involved in cell senescence in glioma","volume":"4","year":"2013","journal-title":"Cell Death Dis"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/hmg\/dds496","article-title":"MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma","volume":"22","year":"2013","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2015.04.002","article-title":"MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma","volume":"207","year":"2015","journal-title":"J. Control. Release"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B24","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/neuonc\/not055","article-title":"MicroRNA-128 coordinately targets polycomb repressor complexes in glioma stem cells","volume":"15","year":"2013","journal-title":"Neuro Oncol"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B25","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/nar\/gkv403","article-title":"DIANA-miRPath v3.0: Deciphering microRNA function with experimental support","volume":"43","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","year":"2005","journal-title":"Cell"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molcel.2007.06.017","article-title":"MicroRNA targeting specificity in mammals: determinants beyond seed pairing","volume":"27","year":"2007","journal-title":"Mol. Cell"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/bioinformatics\/bts043","article-title":"Functional microRNA targets in protein coding sequences","volume":"28","year":"2012","journal-title":"Bioinformatics"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/nar\/gkt393","article-title":"DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows","volume":"41","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1261\/rna.035295.112","article-title":"The microRNA-302-367 cluster suppresses the proliferation of cervical carcinoma cells through the novel target AKT1","volume":"19","year":"2013","journal-title":"Rna"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B31","first-page":"4481","article-title":"Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K\/Akt signaling pathways","volume":"8","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B32","doi-asserted-by":"crossref","first-page":"2042.","DOI":"10.1038\/s41598-017-02058-8","article-title":"MiR-520b as a novel molecular target for suppressing stemness phenotype of head-neck cancer by inhibiting CD44","volume":"7","year":"2017","journal-title":"Sci. Rep"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B33","article-title":"MicroRNA-520b functions as a tumor suppressor in colorectal cancer by inhibiting DCUN1D1","year":"2017","journal-title":"Oncol. Res"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B34","article-title":"MicroRNA-520b suppresses proliferation, migration, and invasion of spinal osteosarcoma cells via downregulation of frizzled-8","year":"2017","journal-title":"Oncol. Res"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B35","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3892\/or.2016.5320","article-title":"MicroRNA-302a targets GAB2 to suppress cell proliferation, migration and invasion of glioma","volume":"37","year":"2017","journal-title":"Oncol. Rep"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B36","doi-asserted-by":"crossref","first-page":"e2713.","DOI":"10.1038\/cddis.2017.117","article-title":"Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth","volume":"8","year":"2017","journal-title":"Cell Death Dis"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B37","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.1007\/s13277-015-4666-6","article-title":"MicroRNA-520b affects the proliferation of human glioblastoma cells by directly targeting cyclin D1","volume":"37","year":"2016","journal-title":"Tumor Biol"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B38","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/onc.2009.497","article-title":"Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21(Waf1\/Cip1)","volume":"29","year":"2010","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B39","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1038\/onc.2010.34","article-title":"Multiple microRNAs modulate p21Cip1\/Waf1 expression by directly targeting its 3\u2019 untranslated region","volume":"29","year":"2010","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B40","doi-asserted-by":"crossref","first-page":"6426","DOI":"10.1128\/MCB.00359-08","article-title":"Oct4\/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells","volume":"28","year":"2008","journal-title":"Mol. Cell. Biol"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B41","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1158\/2159-8290.CD-12-0502","article-title":"De-repression of PDGFR\u03b2 transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients","volume":"3","year":"2013","journal-title":"Cancer Discov"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B42","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.4161\/cc.7.24.7244","article-title":"Deconstructing feedback-signaling networks to improve anticancer therapy with mTORC1 inhibitors","volume":"7","year":"2008","journal-title":"Cell Cycle"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B43","author":"Phase II axitinib (AG-013736) in elderly glioblastoma multiforme (GBM) patients","year":"2012"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B44","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1200\/JCO.2013.49.6968","article-title":"Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial","volume":"31","year":"2013","journal-title":"J. Clin. Oncol"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B45","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1200\/JCO.2008.20.7944","article-title":"Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma","volume":"27","year":"2009","journal-title":"J. Clin. Oncol"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/JTO.0b013e31829cebbb","article-title":"High-dose crizotinib for brain metastases refractory to standard-dose crizotinib","volume":"8","year":"2013","journal-title":"J. Thorac. Oncol"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B47","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/neuonc\/nor121","article-title":"\u2018Pulsatile\u2019 high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer","volume":"13","year":"2011","journal-title":"Neuro Oncol"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B48","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nbt.1862","article-title":"Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells","volume":"29","year":"2011","journal-title":"Nat. Biotechnol"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B49","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/cdd.2011.89","article-title":"The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network","volume":"19","year":"2012","journal-title":"Cell Death Differ"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2006.12.003","article-title":"Aneuploidy Acts Both Oncogenically and as a Tumor Suppressor","volume":"11","year":"2007","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B51","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/ijc.29606","article-title":"Expression of the miR-302\/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypes","volume":"137","year":"2015","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B52","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00280-012-2043-3","article-title":"Overcoming acquired resistance to anticancer therapy: Focus on the PI3K\/AKT\/mTOR pathway","volume":"71","year":"2013","journal-title":"Cancer Chemother. Pharmacol"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc3860","article-title":"PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting","volume":"15","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B54","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/nar\/gkp1005","article-title":"PrimerBank: A resource of human and mouse PCR primer pairs for gene expression detection and quantification","volume":"38","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B55","doi-asserted-by":"crossref","first-page":"e45.","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B56","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/sj.gt.3301015","article-title":"Mechanisms of gene transfer mediated by lipoplexes associated with targeting ligands or pH-sensitive peptides","volume":"6","year":"1999","journal-title":"Gene Ther"},{"key":"key\n\t\t\t\t20171103044530_ddx323-B57","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","year":"2006","journal-title":"Nat. Protoc"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/26\/22\/4375\/21520310\/ddx323.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T08:33:14Z","timestamp":1570005194000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/hmg\/article\/26\/22\/4375\/4082908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,16]]},"references-count":57,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2017,8,16]]},"published-print":{"date-parts":[[2017,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddx323","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11,15]]},"published":{"date-parts":[[2017,8,16]]}}}